Search

everythinglearnresearchcommunity

for

Search:↓

Quercetin and kaempferol may be effective and safe natural treatments for hair loss.

M50054 may help treat hepatitis and hair loss from chemotherapy.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

CMC2.24 and CMC2.23 reduce melanin safely and effectively.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Ruxolitinib can help regrow hair in severe alopecia areata.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Skin reactions from cancer treatments might predict how well the treatments work.

Recent findings advanced understanding of cancer mechanisms and potential treatments.

LDE225 is a promising skin-applied treatment for basal cell carcinoma with good skin penetration and effectiveness.

Nestin helps identify certain melanoma cells in nodular melanoma.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

Blocking a specific receptor slows down hair loss in mice.

A new gene mutation may allow some piebaldism patients to regain skin color in white patches.

Upadacitinib improves life quality for Alopecia Areata patients without worsening skin issues.

Protein Kinase Cε increases skin sensitivity to UV damage and skin cancer risk.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Ruxolitinib helped a patient with alopecia areata regrow hair.

Hair follicle samples effectively show how well the drug MK-0752 targets and engages with the Notch pathway.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Removing both KLK5 and KLK7 proteins can prevent death and skin issues in Netherton syndrome.

TSC22D genes are key in metabolic diseases and cancer, offering potential as treatment targets.

The committee decided not to approve the drug due to low effectiveness and high risks.

VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.